Corticosteroids Market Overview

The corticosteroids market was valued at USD 4.71 billion in 2023 and is projected to reach USD 6.91 billion by 2033, growing at a 4.2% CAGR.

Rheumatology led with 35% market share in 2023, while dermatology is the fastest-growing segment, boasting a 5.1% CAGR. Topical corticosteroids dominated the market, holding 49% of the share.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5111

Understanding Corticosteroids Key Insights and Applications

The Forum of International Respiratory Societies estimates that over 4.5 million lives have been lost due to the ongoing pandemic, with respiratory issues being the primary cause. During this crisis, corticosteroids have played a crucial role in treating respiratory diseases.

Corticosteroids are steroid hormones naturally produced by the adrenal cortex, located on top of each kidney. These hormones regulate essential processes such as metabolism, immune response, and electrolyte balance. They are categorized into two main types:

• Glucocorticoids: Hormones like cortisol that regulate metabolism and the immune system.
• Mineralocorticoids: Hormones like aldosterone that help maintain electrolyte and water balance.

In medicine, synthetic corticosteroids are widely used for their anti-inflammatory and immunosuppressive properties. Available as oral tablets, topical creams, inhalers, and injections, they are prescribed to manage a variety of conditions, including autoimmune disorders, allergies, asthma, inflammatory joint diseases, and skin conditions.

Healthcare providers carefully monitor corticosteroid use to minimize potential side effects such as bone loss, immune suppression, and metabolic disturbances. Treatment plans are tailored to ensure the benefits outweigh the risks, with dosages adjusted based on individual needs.

The rising prevalence of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD) has driven up demand for inhaled corticosteroids as part of their treatment. Additionally, corticosteroids play a role in cancer care, helping manage chemotherapy side effects. As cancer treatments evolve, the demand for supportive medications like corticosteroids is expected to grow.

With their versatile applications and significant role in managing various health conditions, corticosteroids remain a cornerstone in modern medical treatment.

Recent Developments in the Corticosteroids Market

• August 2022: ReveraGen BioPharma initiated a study to evaluate Vamorolone for treating Becker muscular dystrophy (BMD). In this trial, the first patient received a dose of nandrolone, marking a significant step toward exploring this steroid’s potential as a treatment for various muscular dystrophies.
• April 2022: Eli Lilly and Company tested a combination of Lebrikizumab and topical corticosteroids to treat atopic dermatitis (AD), a chronic skin condition. After 16 weeks, patients showed a remarkable 75% improvement. The combination effectively addressed key symptoms like skin inflammation and itching, offering hope for better AD management.

Leading Companies in the Corticosteroids Market

• Pfizer
• Novartis
• Merck & Co., Inc.
• GlaxoSmithKline
• AstraZeneca
• Bausch Health Companies Inc.
• Galderma
• Cipla
• Sanofi
• Teva Pharmaceutical Industries Ltd.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/corticosteroids-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5111

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare